US Visa Restrictions Target Alleged Fentanyl Supply Network

US Targets Alleged Fentanyl Network

The United States has imposed visa restrictions on 13 individuals linked to an India-based online pharmacy accused of selling counterfeit prescription pills laced with fentanyl to people in America. The action is part of Washington’s wider crackdown on global opioid trafficking networks.

According to the U.S. Department of State, the restrictions apply to people associated with KS International Traders, also known as KS Pharmacy, and its owner. U.S. officials allege the company generated revenue through the sale of fake prescription medicines containing illicit fentanyl.

Why The Case Matters

Fentanyl is a powerful synthetic opioid linked to thousands of overdose deaths in the United States. Authorities say traffickers often disguise fentanyl as regular prescription medicines, making it highly dangerous for unsuspecting buyers.

The case also shows how U.S. visa powers are being used as an enforcement tool against people accused of supporting drug trafficking. Earlier, U.S. authorities had also sanctioned KS International Traders and two Indian nationals over alleged links to counterfeit fentanyl-laced pills.

US-India Drug Enforcement Focus

The United States and India continue to cooperate under drug policy frameworks to fight illegal drug trafficking, strengthen supply chains, and address the public health impact of synthetic opioids.